Search

everythinglearnresearchcommunity

for

Search:↓

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

Hair loss occurred after a COVID-19 infection.

People who had severe COVID-19 are more likely to experience hair loss.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

COVID-19 can cause temporary hair loss.

COVID-19 and its vaccines can cause various skin issues, with urticaria being the most common.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

Hepatitis B vaccination can trigger HSP, and vitamin D correction and tonsillectomy can effectively manage it.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

The pandemic changed how often certain skin conditions were diagnosed.

Social media is increasingly used in dermatology for education and networking but has risks like misinformation and privacy issues.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Social media data can help track and predict COVID-19 symptoms and trends.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.